Problem: The prevalence of regulatory T cells (Tregs) is lower in preeclampsia (PE) compared to healthy pregnancy (HP). However, the proportion of recently described Treg subtypes has not been investigated.
Introduction
Preeclampsia (PE) is an immune-mediated syndrome usually developing in the third trimester of pregnancy characterized by an excessive maternal systemic inflammatory response with activation of both the innate and adaptive arms of the immune system. 1, 2 The maternal immune tolerance towards the developing semi-allogeneic fetus present in healthy pregnancy (HP) is compromised in PE. Activated neutrophils, monocytes, and natural killer cells initiate inflammation, which induces endothelial dysfunction, and activated T cells may support inadequate maternal tolerance mechanisms. An important feature of systemic inflammation in PE is the absence of Th2 skewness characteristic for HP, and thus the predominance of a Th1-type immunity. 3 Regulatory T cells (Tregs) are mediators of the maternal immune tolerance towards the developing fetus. The FoxP3 transcription factor has been widely used as an intracellular marker to identify this subset. Tregs modulate the functions of other T cells (both CD4+ and CD8+), primarily through secretion of cytokines, including IL-10 and TGF-β. 4, 5 Evidence for the role of Treg cells in establishing fetal tolerance during pregnancy comes from animal studies, demonstrating a significantly increased rate of fetal resorption in allogeneic gestations of Treg-deficient mice. [6] [7] [8] Lower than normal Treg frequency may contribute to the exaggerated systemic inflammation also in humans in PE. Indeed, a number of groups including ours demonstrated that the prevalence of peripheral Tregs is lower in PE compared to healthy pregnancy. [9] [10] [11] [12] [13] While these studies mainly investigated peripheral blood, the distribution of Tregs in the decidua might differ. Earlier investigations provided evidence for the selective migration of fetus-specific Tregs from peripheral blood to the decidua, further emphasizing the importance of studying Tregs at the fetomaternal interface. expression on T cells is associated with limited proliferative capacity and reduced immune suppression in vivo. [25] [26] [27] [28] [29] Interestingly, one of the ligands for CD279, CD274 (PD-L1), has been shown to negatively regulate Tregs by inhibiting STAT-5 phosphorylation at sites of chronic inflammation. Thus PD-1 and its ligand appear to be a major inhibitory receptor pathway involved in T cell exhaustion. 26 In this study, we aimed to compare the peripheral prevalence of activated T cells and Treg subtypes, such as naive and effector, thymic and extrathymic, as well as exhausted Tregs in PE and HP.
Methods

Sample collection
We enrolled 19 women with PE at on average the 34th gestational week of pregnancy. PE was diagnosed according to standard internationally accepted criteria. These include hypertension (defined as systolic blood pressure and/or diastolic blood pressure ≥ 140 mmHg and ≥ 90 mmHg, respectively) occurring after 20 weeks of gestation, and proteinuria (defined as presence of ≥ 0.3 g protein in a 24 hour urine specimen). As controls, 21 healthy, agematched pregnant women at on average the 36th gestational week were enrolled. Clinical characteristics of participants are summarized in Table I . PE was regarded as severe if any of the following criteria was present: blood pressure ≥ 160 mmHg systolic or ≥ 110 mmHg diastolic, or proteinuria ≥ 5 g/24 h (or 3+ on dipstick). Early onset of PE was defined as onset of the disease before 34 weeks of gestation. Informed consent was obtained from all subjects, and our study was reviewed and approved by an independent ethical committee of the institution (Scientific and Research Ethics Committee, Semmelweis University, Budapest, Hungary). The study was adhered to the tenets of the most recent revision of the Declaration of Helsinki.
Flow cytometry
Peripheral blood mononuclear cells (PBMCs) were separated by a standard density gradient Mouse IgG1 antibodies were used as isotype control.
After washing, cells were analyzed on a BD FACSAria flow cytometer (BD Biosciences).
Data were processed using the FACSDiVa software. 200 000 cells per sample were recorded.
Statistics
Data are expressed as median and interquartile range (IQR). Comparisons between two
sample populations were made with the Mann-Whitney U test, as a test of normality (according to Kolmogorov-Smirnoff) indicated non-normal distribution of data; p-values less than 0.05 were considered significant. Statistics were calculated using the GraphPad software (Prism version 5.00 for Windows, GraphPad Software, San Diego, CA, USA).
Results
Our results are summarized in Figure 1 and 
Discussion
In this study, we analyzed the prevalence of recently described regulatory T cell subsets in PE compared to HP. As many studies have noted before, 9-13 the percentage of Tregs, identified as CD4+ CD25hi FoxP3+ cells, was lower in PE than in HP, contributing to the compromised maternal immune tolerance towards the semi-allogeneic fetus characteristic for PE, and to the loss of control over activated T cells. Indeed, the proportion of CD4+ CD25+ FoxP3+
CD45RA-activated T cells was higher among CD4+ T cells in PE compared to HP. This might in turn contribute to the increased Th1 type response and imbalance of Th1/Th2 ratio. Treg cells appear to be unaffected. A further factor that may contribute to the decreased functionality of Tregs in PE is that the prevalence of exhausted, functionally less active Tregs (CD4+ CD25hi FoxP3+ CD279+) is higher compared to HP. In line with these findings in pregnancy, an exhausted and dysfunctional phenotype of Tregs has been reported before in chronic disease and infection. 24 The combination of lower effector Treg and higher exhausted Treg prevalence may account not only for the lower Treg proportion, but also for the observed decrease in the functionality of Tregs in PE. 30 The Helios transcription factor belongs to the Ikaros family and is expressed by thymicderived Treg cells. 17 Samstein et al. reported that extrathymic generation of regulatory T cells enforces maternal-fetal tolerance in placental mammals. 7 In addition, Hsu et al. demonstrated that the expansion of CD4+ Helios-Foxp3+ iTreg cells, rather than CD4+ Helios+ Foxp3+ nTreg cells, accounts for Treg expansion in HP. This expansion was found to be even more pronounced in the decidua, where an overrepresentation of iTreg cells was found. In PE, however, impaired systemic iTreg cell expansion was described, associated with a lack of iTreg cell overrepresentation in the decidua. 31 On Earlier studies demonstrated that the prevalence of Tregs is decreased not only on the systemic level in peripheral blood of PE patients, but also locally, within the decidual tissue. 14, 16 A limitation of our study is that our findings represent circumstances in peripheral blood only. Therefore, further studies on the expression of the investigated Treg cell subtypes in the decidua are required to identify their role played in mediating tolerance at the fetomaternal interface. Moreover, the functional activity of Treg cell subsets should also be examined in healthy pregnancy and preeclampsia in future studies. 
Conclusion
